Kerusso Capital Management LLC Bristol Myers Squibb CO Transaction History
Kerusso Capital Management LLC
- $162 Billion
- Q2 2025
A detailed history of Kerusso Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kerusso Capital Management LLC holds 17,797 shares of BMY stock, worth $828,450. This represents 0.51% of its overall portfolio holdings.
Number of Shares
17,797
Previous 48,453
63.27%
Holding current value
$828,450
Previous $2.96 Billion
72.12%
% of portfolio
0.51%
Previous 1.88%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,662Shares Held
1.63BCall Options Held
24.8MPut Options Held
23.4M-
Vanguard Group Inc Valley Forge, PA195MShares$9.07 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.39 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.03 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.41 Billion0.24% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...